Latest reported quarter: Q2, ended Jun 2026 · reported in EUR
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Revenue as Reported | €4.36B | €3.91B | €17.83B | €5.10B | €4.30B |
| Total Operating Revenue | €4.36B | €3.91B | €17.83B | €5.10B | €4.30B |
| Cost of Revenue | €2.21B | €2.14B | €9.78B | €2.81B | €2.39B |
| Gross Profit | €2.15B | €1.77B | €8.06B | €2.29B | €1.91B |
| Operating Expense | €1.54B | €1.52B | €6.61B | €1.72B | €1.58B |
| Selling and Admin Expenses | €1.21B | €1.18B | €4.97B | €1.31B | €1.18B |
| -Selling & Marketing Expense | €1.05B | €1.01B | €4.34B | €1.15B | €1.02B |
| -General & Admin Expense | €154.00M | €177.00M | €628.00M | €158.00M | €154.00M |
| Research & Development | €484.00M | €394.00M | €1.70B | €427.00M | €414.00M |
| Other Operating Expenses | -€151.00M | -€54.00M | -€61.00M | -€9.00M | -€11.00M |
| Operating Profit | €610.00M | €242.00M | €1.45B | €565.00M | €330.00M |
| Net Non-Operating Interest Income (Expense) | -€62.00M | -€48.00M | -€216.00M | -€53.00M | -€57.00M |
| Non-Operating Interest Income | €33.00M | €35.00M | €83.00M | €8.00M | €21.00M |
| Non-Operating Interest Expense | €95.00M | €83.00M | €294.00M | €56.00M | €78.00M |
| Other Income (Expense) | -€1.00M | -€4.00M | -€50.00M | -€44.00M | €2.00M |
| Earnings from Equity Interest | -€1.00M | -€4.00M | -€9.00M | -€3.00M | €2.00M |
| Pretax Profit | €546.00M | €190.00M | €1.18B | €466.00M | €275.00M |
| Tax | €160.00M | €44.00M | €282.00M | €74.00M | €87.00M |
| Net Profit | €386.00M | €146.00M | €897.00M | €398.00M | €187.00M |
| Profit from Continuing Operations | €386.00M | €146.00M | €901.00M | €393.00M | €188.00M |
| Net Income from Discontinuous Operations | €0.00 | €0.00 | -€4.00M | €4.00M | -€1.00M |
| Minority Interests | €2.00M | -€5.00M | €1.00M | €2.00M | €3.00M |
| Net Income to Parent Company | €384.00M | €151.00M | €895.00M | €395.00M | €184.00M |
| Net Income to Common Stockholders | €384.00M | €151.00M | €895.00M | €395.00M | €184.00M |
| Basic EPS | €0.40 | €0.16 | €0.94 | €0.42 | €0.19 |
| Diluted EPS | €0.40 | €0.16 | €0.93 | €0.42 | €0.19 |
| Dividend Per Share | €0.87 | €0.00 | €0.85 | €0.00 | €0.00 |
| Total Other Finance Costs | – | – | €5.00M | – | – |
| Gain on Sale of Security | – | – | -€17.00M | – | – |
| Special Income (Charges) | – | – | -€24.00M | – | – |
| -Less:Impairment of Capital Assets | – | – | €0.00 | – | – |
| -Gain on Sale Of Business | – | – | -€25.00M | – | – |
| -Gain on Sale of Property/Plant/Equipment | – | – | €1.00M | – | – |
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €26.70B | €27.27B | €26.94B | €26.94B | €26.34B |
| Total Current Assets | €9.33B | €9.78B | €9.93B | €9.93B | €9.28B |
| Cash and Cash Equivalents & Short-Term Investments | €1.79B | €2.59B | €2.79B | €2.79B | €1.91B |
| -Cash and Cash Equivalents | €1.79B | €2.59B | €2.79B | €2.79B | €1.91B |
| Receivables | €3.60B | €3.31B | €3.95B | €3.95B | €3.32B |
| -Accounts Receivable | €3.55B | €3.26B | €3.34B | €3.34B | €3.27B |
| -Taxes Receivable | €47.00M | €45.00M | €60.00M | €60.00M | €50.00M |
| Inventory | €3.22B | €3.11B | €2.87B | €2.87B | €3.26B |
| Other Current Assets | €665.00M | €628.00M | -€5.00M | -€5.00M | €593.00M |
| Total Non-Current Assets | €17.37B | €17.48B | €17.01B | €17.01B | €17.06B |
| Net PPE | €2.17B | €2.18B | €2.22B | €2.22B | €2.22B |
| Investments and Advances | €862.00M | €850.00M | €852.00M | €852.00M | €765.00M |
| -Long Term Equity Investment | €151.00M | €142.00M | €148.00M | €148.00M | €146.00M |
| Non Current Accounts Receivables | €202.00M | €220.00M | €210.00M | €210.00M | €213.00M |
| Goodwill and Other Intangible Assets | €12.24B | €12.30B | €11.84B | €11.84B | €11.92B |
| -Goodwill | €9.68B | €9.61B | €9.27B | €9.27B | €9.34B |
| -Other Intangible Assets | €2.56B | €2.69B | €2.57B | €2.57B | €2.58B |
| Non-Current Deferred Assets | €1.77B | €1.81B | €1.77B | €1.77B | €1.80B |
| Other Non-Current Assets | €128.00M | €121.00M | €119.00M | €119.00M | €146.00M |
| Total Liabilities | €15.23B | €15.85B | €15.96B | €15.96B | €15.76B |
| Total Current Liabilities | €7.42B | €7.43B | €7.51B | €7.51B | €7.03B |
| Payables | €2.29B | €2.19B | €2.25B | €2.25B | €1.90B |
| -Accounts Payable | €2.08B | €1.99B | €1.93B | €1.93B | €1.71B |
| -Total Tax Payable | €168.00M | €198.00M | €307.00M | €307.00M | €182.00M |
| -Dividends Payable | €37.00M | – | – | – | – |
| Current Accrued Expenses | €1.44B | €1.33B | €1.74B | €1.74B | €1.44B |
| Short-Term Debt and Capital Lease Obligation | €1.15B | €1.21B | €1.00B | €1.00B | €1.15B |
| -Current Debt | €1.15B | €1.21B | €793.00M | €793.00M | €1.15B |
| Current Provisions | €553.00M | €602.00M | €712.00M | €712.00M | €691.00M |
| Current Deferred Liabilities | €1.58B | €1.62B | €1.49B | €1.49B | €1.52B |
| Other Current Liabilities | €409.00M | €494.00M | €321.00M | €321.00M | €334.00M |
| Total Non-Current Liabilities | €7.80B | €8.42B | €8.44B | €8.44B | €8.73B |
| Long Term Debt and Capital Lease Obligation | €6.32B | €6.89B | €6.81B | €6.81B | €7.24B |
| -Long Term Debt | €6.32B | €6.89B | €6.05B | €6.05B | €7.24B |
| Non-Current Liabilities | €865.00M | €879.00M | €915.00M | €915.00M | €956.00M |
| Non-Current Deferred Liabilities | €541.00M | €529.00M | €551.00M | €551.00M | €492.00M |
| Other Non-Current Liabilities | €80.00M | €117.00M | €44.00M | €44.00M | €41.00M |
| Total Equity | €11.48B | €11.42B | €10.99B | €10.99B | €10.58B |
| Stockholders' Equity | €11.45B | €11.39B | €10.96B | €10.96B | €10.55B |
| Capital Stock | €197.00M | €193.00M | €193.00M | €193.00M | €193.00M |
| -Common Stock | €197.00M | €193.00M | €193.00M | €193.00M | €193.00M |
| Additional Paid-In Capital | €7.67B | €7.21B | €7.21B | €7.21B | €7.17B |
| Retained Earnings | €3.18B | €3.71B | €3.58B | €3.58B | €3.21B |
| Less: Treasury Stock | €113.00M | €265.00M | €298.00M | €298.00M | €312.00M |
| Gains/Losses Not Affecting Retained Earnings | €644.00M | €527.00M | €291.00M | €291.00M | €296.00M |
| Other Equity Interests | -€130.00M | €12.00M | -€16.00M | -€16.00M | -€1.00M |
| Minority Interests | €29.00M | €26.00M | €32.00M | €32.00M | €31.00M |
| -Due from Related Parties Current | – | – | €19.00M | €19.00M | – |
| -Other Receivables | – | – | €527.00M | €527.00M | – |
| Prepaid Assets | – | – | €180.00M | €180.00M | – |
| -Gross PPE | – | – | €5.92B | €5.92B | – |
| -Accumulated Depreciation | – | – | -€3.71B | -€3.71B | – |
| -Available for Sale Securities | – | – | €324.00M | €324.00M | – |
| -Other Payable | – | – | €17.00M | €17.00M | – |
| -Current Capital Lease Obligation | – | – | €207.00M | €207.00M | – |
| -Long Term Capital Lease Obligation | – | – | €757.00M | €757.00M | – |
| Derivative Product Liabilities | – | – | €123.00M | €123.00M | – |
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | €376.00M | €188.00M | €1.17B | €1.39B | €327.00M |
| Net cash flow from continuing operations | €377.00M | €190.00M | €1.17B | €1.39B | €327.00M |
| Net Income from Continuing Operations | €386.00M | €146.00M | €901.00M | €394.00M | €188.00M |
| Gain/Loss from Continuing Operations | -€98.00M | €17.00M | €32.00M | €27.00M | -€2.00M |
| Depreciation & Depletion & Amortization | €381.00M | €265.00M | €1.12B | €278.00M | €303.00M |
| Deferred Tax | €160.00M | €44.00M | €282.00M | €74.00M | €87.00M |
| Other Non-Cash Items | €23.00M | €8.00M | €294.00M | €73.00M | €46.00M |
| Change in Working Capital | -€329.00M | -€263.00M | -€1.23B | €581.00M | -€240.00M |
| -Change in Receivables | -€301.00M | €219.00M | -€53.00M | -€175.00M | -€4.00M |
| -Change in Inventory | -€113.00M | -€226.00M | -€115.00M | €355.00M | -€102.00M |
| -Change in Payables and Accrued Expense | €136.00M | -€115.00M | €97.00M | €360.00M | -€80.00M |
| -Change in Other Current Liabilities | €19.00M | €18.00M | €54.00M | €50.00M | €12.00M |
| -Change In Other Working Capital | -€70.00M | -€159.00M | -€1.22B | -€9.00M | -€66.00M |
| Net cash flow from investing | -€19.00M | -€406.00M | -€737.00M | -€196.00M | -€158.00M |
| Net Cash Flow from Continuing Investing Activities | -€20.00M | -€406.00M | -€736.00M | -€196.00M | -€158.00M |
| Capital Expenditure | -€130.00M | -€136.00M | -€532.00M | -€148.00M | -€135.00M |
| Net PPE Purchase and Sale | €3.00M | €3.00M | €9.00M | €2.00M | €3.00M |
| Net Intangibles Purchase and Sale | -€27.00M | -€27.00M | -€136.00M | -€44.00M | -€23.00M |
| Net Business Purchase and Sale | €121.00M | -€221.00M | -€25.00M | -€18.00M | €3.00M |
| Net Investment Purchase and Sale | €13.00M | -€25.00M | -€52.00M | €12.00M | -€6.00M |
| Net Other Investing Changes | €1.00M | – | -€1.00M | €0.00 | – |
| Financing Cash Flow | -€1.15B | -€23.00M | €107.00M | -€322.00M | -€68.00M |
| Net Cash Flow from Continuing Financing Activities | -€1.15B | -€23.00M | €107.00M | -€322.00M | -€68.00M |
| Net Issuance Payments Of Debt | -€767.00M | -€34.00M | €424.00M | -€327.00M | -€42.00M |
| Net Common Stock Issuance | -€65.00M | €12.00M | €13.00M | €5.00M | €7.00M |
| Cash Dividends Paid | -€321.00M | – | -€328.00M | €0.00 | -€33.00M |
| Net Other Financing Charges | -€1.00M | -€1.00M | -€2.00M | €0.00 | – |
| Ending Cash Balance | €1.79B | €2.59B | €2.79B | €2.79B | €1.91B |
| Net Change in Cash | -€797.00M | -€241.00M | €532.00M | €872.00M | €101.00M |
| Beginning Cash Balance | €2.59B | €2.79B | €2.40B | €1.91B | €1.82B |
| Effect of Exchange Rate Changes | -€6.00M | €39.00M | -€139.00M | €10.00M | -€11.00M |
| Free Cash Flow | €219.00M | €25.00M | €504.00M | €1.20B | €169.00M |
No comments yet — be the first to weigh in on PHG.